Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - acetylcysteine, quantity: 6 g - injection - excipient ingredients: sodium hydroxide; water for injections - as an antidote for paracetamol poisoning: acetadote injection is indicated in the treatment of paracetamol overdose to protect against hepatoxicity.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - zoledronic acid monohydrate 4.3mg equivalent to zoledronic acid 4 mg - concentrate for infusion - 4 mg/5ml - active: zoledronic acid monohydrate 4.3mg equivalent to zoledronic acid 4 mg excipient: mannitol sodium citrate dihydrate water for injection - prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone

Malta - English - Medicines Authority

heaton k.s. na pankraci 14, 140 00 praha 4, czech republic - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use

Malta - English - Medicines Authority

heaton k.s. na pankraci 14, 140 00 praha 4, czech republic - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use

Philippines - English - FDA (Food And Drug Administration)

na - na - na

Philippines - English - FDA (Food And Drug Administration)

n/a; distributor: n/a - na - na - na

Philippines - English - FDA (Food And Drug Administration)

n/a; distributor: n/a - na - na - na

Philippines - English - FDA (Food And Drug Administration)

n/a; distributor: n/a - na - na - na

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sodium acetate, quantity: 0.164 g/ml - injection, concentrated - excipient ingredients: water for injections - sodium acetate concentrated injection is indicated for inclusion in total parenteral nutrition (tpn) solutions as an electrolyte source. sodium acetate may also be added to parenteral solution to increase ph. sodium acetate concentrated injection may be used for the treatment of hyponatraemia (sodium depletion) states, in cases where oral sodium therapy is contraindicated or not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - docetaxel, quantity: 160 mg - injection, concentrated - excipient ingredients: ethanol absolute; polysorbate 80; citric acid monohydrate - docetaxel concentrate for solution for infusion is indicated for;,breast cancer -,metastatic breast cancer : docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. ,docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. ,docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours overexpress her2 and who previously have not received chemotherapy for metastatic disease. ,adjuvant treatment of breast cancer : docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with node-positive breast cancer. ,doxorubicin and cyclophosphamide followed by docetaxel in combination with trastuzumab (ac-th) is indicated for the adjuvant treatment of patients with operable breast cancer whose tumours overexpress her2. ,docetaxel in combination with carboplatin and trastuzumab (tch) is indicated for the adjuvant treatment of patients with operable breast cancer whose tumours overexpress her2. ,docetaxel in combination with cyclophosphamide is indicated for the adjuvant treatment of operable breast cancer with a primary tumour of ? 1cm and < 7cm. ,non small cell lung cancer -,docetaxel is indicated for the treatment of patients with locally advanced or metastatic non small cell lung cancer, including those who have failed platinum-based chemotherapy. ,ovarian cancer - docetaxel is indicated for the treatment of metastatic carcinoma of the ovary after failure of first-line or subsequent chemotherapy. ,prostate cancer -,docetaxel is indicated for the treatment of patients with androgen independent (hormone refractory) prostate cancer. ,head and neck cancer -,docetaxel, in combination with cisplatin and fluorouracil is indicated as induction treatment prior to chemoradiotherapy, for the treatment of patients with locally advanced, squamous cell carcinoma of the head and neck, who have low probability of surgical cure, require organ preservation or where the tumour is technically unresectable.